Digital Health Views & Analysis

Views & Analysis

Frontiers Health Steering Committee spotlight – Paul Tunnah

As the Frontiers Health 2022 conference in Milan on 20th to 21st October draws ever nearer, pharmaphorum has been catching up with members of the event’s Steering Committee to find out more

Views & Analysis

How the food allergy sector is benefitting from health tech'...

For the 32 million individuals in the US with food allergies, more research into symptoms, causes, and treatments has been long sought after, but historically underfunded.

Views & Analysis

Frontiers Health Steering Committee spotlight – Fredrik Debo...

As we enter October and the Frontiers Health 2022 conference in Milan, we’re shining a spotlight on some of the Steering Committee members who have helped make the event what it is.

Views & Analysis

Frontiers Health Steering Committee spotlight: Roberto Ascio...

As we close in on Frontiers Health 2022, pharmaphorum is chatting with members of the Steering Committee to give you a sneak peek of what to expect in Milan. Interested in signing up?

Views & Analysis

Considerations for Mobile Health Technology Developers: Part...

In Part 1 of this series, general wellness devices and mobile me

Views & Analysis

Hollywood and the Metaverse’s effect on pharma’s content

Gaurav Kapoor, co-founder and executive vice president of Indegene, tells pharmaphorum how pharma can take lessons from the entertainment industry and prepare for the Metaverse to enhance c

Frontiers Health Steering Committee spotlight – Paul Tunnah

How the food allergy sector is benefitting from health tech'...

Frontiers Health Steering Committee spotlight – Fredrik Debo...

Frontiers Health Steering Committee spotlight: Roberto Ascio...

Considerations for Mobile Health Technology Developers: Part...

Hollywood and the Metaverse’s effect on pharma’s content

Merck rare tumour drug Ezmekly backed for NHS use

Discover a new era of healthcare panel engagement: Grounded ...

Views & Analysis

Editor's Picks